(Q39448700)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22049994%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Isolation of human mAbs that directly modulate FMS-related tyrosine kinase 3 signaling (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22049994%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22049994%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Yoshiki Akatsuka

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22049994%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Yukiya Yamamoto

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22049994%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Sachiko Tsuzuki

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22049994%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Yasushi Akahori

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22049994%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Mariko Sumitomo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22049994%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Yuko Murayama

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22049994%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Kiyoko Yamamoto

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22049994%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Youko Inaguma

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22049994%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Masutaka Tokuda

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22049994%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Akihiro Abe

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22049994%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Nobuhiko Emi

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22049994%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Yoshikazu Kurosawa

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22049994%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

5 December 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22049994%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22049994%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22049994%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22049994%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

350-359

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22049994%20AND%20SRC:MED&resulttype=core&format=json

The roles of FLT3 in hematopoiesis and leukemia

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02141.X

Flt3 mutations and leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02141.X

All hematopoietic cells develop from hematopoietic stem cells through Flk2/Flt3-positive progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02141.X

Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02141.X

FLT3 inhibition in acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02141.X

Fms-like tyrosine kinase 3 ligand stimulation induces MLL-rearranged leukemia cells into quiescence resistant to antileukemic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02141.X

FLT3 ligand impedes the efficacy of FLT3 inhibitors in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02141.X

Isolation of antigen/antibody complexes through organic solvent (ICOS) method

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02141.X

Comprehensive screening for antigens overexpressed on carcinomas via isolation of human mAbs that may be therapeutic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02141.X

Efficient selection for high-expression transfectants with a novel eukaryotic vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02141.X

Antibody fusions with fluorescent proteins: a versatile reagent for profiling protein expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02141.X

Different antiapoptotic pathways between wild-type and mutated FLT3: insights into therapeutic targets in leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02141.X

BCOR as a novel fusion partner of retinoic acid receptor alpha in a t(X;17)(p11;q12) variant of acute promyelocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02141.X

MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02141.X

Resistance to FLT3 inhibition in an in vitro model of primary AML cells with a stem cell phenotype in a defined microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02141.X

FLT3 ligand causes autocrine signaling in acute myeloid leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02141.X

FLT3 inhibition and mechanisms of drug resistance in mutant FLT3-positive AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02141.X

Mechanisms of resistance to FLT3 inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02141.X

Structural insights into the extracellular assembly of the hematopoietic Flt3 signaling complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02141.X

Anchoring of FLT3 in the endoplasmic reticulum alters signaling quality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02141.X

Mislocalized activation of oncogenic RTKs switches downstream signaling outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02141.X

EGFR antagonists in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02141.X

Comparing antibody and small-molecule therapies for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02141.X

Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02141.X

Human antibody RNase fusion protein targeting CD30+ lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02141.X

Granzyme B-H22(scFv), a human immunotoxin targeting CD64 in acute myeloid leukemia of monocytic subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02141.X

Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02141.X

Targeting MLL-AF4 with short interfering RNAs inhibits clonogenicity and engraftment of t(4;11)-positive human leukemic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02141.X

The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02141.X

Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02141.X

Prevention of peripheral tolerance by a dendritic cell growth factor: flt3 ligand as an adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02141.X